FDA Approves Expanded MRI Compatibility for Emerging Spinal Cord Stimulation Modality
Expanded MRI labeling for Abbott’s Proclaim™ XR Spinal Cord Stimulation System may facilitate increased efficiency and quality of MRI scans.
The Food and Drug Administration (FDA) has reportedly approved new labeling that removes limits on lead tip allocation and the amount of radiofrequency power employed with MRI scans in conjunction with the Proclaim XR Spinal Cord Stimulation (SCS) System with Octrode™ leads.
The expanded MRI labeling enables clinicians to place the Octrode lead tips anywhere along the spine without hampering the use of MRI scans for approved conditions, according to Abbott, the manufacturer of the Proclaim XR SCS System. The company said the new labeling also removes restrictions on the use of radiofrequency energy for patients with the Proclaim XR SCS System if the MRI device is in normal operating mode.
There may be increased efficiency and safety as well. While the FDA usually requires radiologists to pause MRIs for 30 to 60 minutes between scan cycles due to potential concerns about radiofrequency energy heating up an implant and damaging surrounding tissue, Abbott noted the expanded MRI labeling allows radiologists to wait only 30 minutes between scan cycles of 30 minutes when assessing patients who have an implanted Proclaim XR SCS System.
“The expanded labeling and reduced scan time address two major issues we face with these implantable devices. By improving the quality of imaging, as well as the experience for both the patient and the radiologist, I can now enable more of my existing and new patients to benefit from MRI scans improving their care,” explained Steven Falowski, M.D., a neurosurgeon who is affiliated with Neurosurgical Associates of Lancaster in Lancaster, Pa.
“Now more clinicians can utilize MRIs to improve quality of care among a patient population with complex needs,” added Timothy Deer, M.D., the president and chief executive officer with the Spine and Nerve Centers of the Virginias in West Virginia. “It allows clinicians to get to the source of a particular issue in less time and without fear of compromising safety or creating complications.”
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
July 22nd 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Stroke MRI Study Assesses Impact of Motion Artifacts Upon AI and Radiologist Lesion Detection
July 16th 2025Noting a 7.4 percent incidence of motion artifacts on brain MRI scans for suspected stroke patients, the authors of a new study found that motion artifacts can reduce radiologist and AI accuracy for detecting hemorrhagic lesions.
